fatigue, fever, nausea, loss of appetite, abdominal pain, vomiting, joint pain, dark urine, clay-colored bowel movements and Jaundice (yellowing of the eyes or skin).
The researchers believe the results indicate the need to better comprehend the biological, behavioral and social factors linked to the contraction of Hep C in women. And further research could explain why medication-assisted treatment programs designed for people with opioid addiction lowered the risk of Hep C in more men than women.
Future research will also look to determine if the variations in immune cell composition or hormonal activities between men and women factor into these discoveries.
Author: Cesar Gamboa
Cesar Gamboa is a staff reporter and editor for Addiction Now covering topics ranging from legislation to scientific studies. He was previously a general assignment reporter for the Orange County Register. SoCal raised, lover of books, and avid mountain biker (when he wants to be). He can be reached at cesarg@addictionnow.com.
